HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Robert J. Keenan Si M. Pham Bartley P. Griffith Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glassman, L. R. Articles by Griffith, B. P. Search for Related Content PubMed PubMed Citation Articles by Glassman, L. R. Articles by Griffith, B. P.

J Thorac Cardiovasc Surg 1995;110:723-0727
© 1995 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients

Pittsburgh, Pa.

From the Department of Cardiac and Thoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Address for reprints: Lawrence R. Glassman, MD, Department of Cardiac and Thoracic Surgery, New York University Medical Center, 530 First Ave., Suite 6-D, New York, NY 10016

Abstract

Primary graft failure is a catastrophic event in lung transplantation. Failure is characterized by profound abnormalities of gas exchange that are frequently unresponsive to alterations in mechanical ventilation. This condition can be fatal and, if less severe, is usually associated with significant permanent damage to the allograft. We report the use of extracorporeal membrane oxygenation as a means to support lung transplant recipients with severe graft failure. Since 1991, extracorporeal membrane oxygenation has been used on 17 occasions for the temporary support of 16 adult lung transplant recipients. All patients met or exceeded standard National Institutes of Health guidelines for institution of extracorporeal membrane oxygenation. Nine double lung, six single lung, and one heart-lung recipients were supported for 1 to 12 days (mean 4.6±2.2 days). Extracorporeal membrane oxygenation was instituted early, within 7 days of transplantation, in ten patients. Eight early patients (80%) were successfully weaned from extracorporeal membrane oxygenation. Seven of ten (70%) patients were long-term survivors, and five of the seven had normal lung function. In comparison, there were no survivors among six recipients placed on extracorporeal membrane oxygenation for late (7 days) graft dysfunction. Extracorporeal membrane oxygenation is a lifesaving adjunct in recipients with acute graft failure after lung transplantation. Ischemia-reperfusion injury and acute graft dysfunction after lung transplantation can be successfully reversed with early aggressive intervention. (J THORACCARDIOVASCSURG1995;110: 723-7)

This article has been cited by other articles:

				C. Aigner, W. Wisser, S. Taghavi, G. Lang, P. Jaksch, D. Czyzewski, and W. Klepetko Institutional experience with extracorporeal membrane oxygenation in lung transplantation Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 468 - 474. [Abstract] [Full Text] [PDF]

				D. P. Mason, D. J. Boffa, S. C. Murthy, T. R. Gildea, M. M. Budev, A. C. Mehta, A. M. McNeill, N. G. Smedira, J. Feng, T. W. Rice, et al. Extended use of extracorporeal membrane oxygenation after lung transplantation J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 954 - 960. [Abstract] [Full Text] [PDF]

				M. G. Hartwig, J. Z. Appel III, E. Cantu III, S. Simsir, S. S. Lin, C.-C. Hsieh, R. Walczak, S. M. Palmer, and R. D. Davis Jr Improved Results Treating Lung Allograft Failure With Venovenous Extracorporeal Membrane Oxygenation Ann. Thorac. Surg., November 1, 2005; 80(5): 1872 - 1880. [Abstract] [Full Text] [PDF]

				T. Oto, F. Rosenfeldt, M. Rowland, A. Pick, M. Rabinov, A. Preovolos, G. Snell, T. Williams, and D. Esmore Extracorporeal Membrane Oxygenation after Lung Transplantation: Evolving Technique Improves Outcomes Ann. Thorac. Surg., October 1, 2004; 78(4): 1230 - 1235. [Abstract] [Full Text] [PDF]

				S. Gabor, H. Renner, H. Popper, U. Anegg, O. Sankin, V. Matzi, J. Lindenmann, and F.M. Smolle Juttner Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 439 - 442. [Abstract] [Full Text] [PDF]

				S. M. Levine and L. F. Angel Primary Graft Failure: Who Is at Risk? Chest, October 1, 2003; 124(4): 1190 - 1192. [Full Text] [PDF]

				K. Kotani, S. Ichiba, M. Andou, Y. Sano, H. Date, T. Tedoriya, K. Goto, and N. Shimizu Extracorporeal membrane oxygenation with nafamostat mesilate as an anticoagulant for massive pulmonary hemorrhage after living-donor lobar lung transplantation J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 626 - 627. [Full Text] [PDF]

				J. B Zwischenberger and S. K Alpard Artificial lungs: a new inspiration Perfusion, July 1, 2002; 17(4): 253 - 268. [Abstract] [PDF]

				G. Thabut, I. Vinatier, J.-B. Stern, G. Leseche, P. Loirat, M. Fournier, and H. Mal Primary Graft Failure Following Lung Transplantation* : Predictive Factors of Mortality Chest, June 1, 2002; 121(6): 1876 - 1882. [Abstract] [Full Text] [PDF]

				A. Pereszlenyi, G. Lang, H. Steltzer, H. Hetz, A. Kocher, P. Neuhauser, W. Wisser, and W. Klepetko Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 858 - 863. [Abstract] [Full Text] [PDF]

				M. Kurusz, J. D Roach Jr, R. A Vertrees, M. K Girouard, and S. D Lick Leukocyte filtration in lung transplantation Perfusion, March 1, 2002; 17(2_suppl): 63 - 67. [Abstract] [PDF]

				M. Struber, J. M. Hohlfeld, T. Kofidis, G. Warnecke, J. Niedermeyer, S. P. Sommer, and A. Haverich Surfactant function in lung transplantation after 24 hours of ischemia: Advantage of retrograde flush perfusion for preservation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 98 - 103. [Abstract] [Full Text] [PDF]

				M. Struber, M. Wilhelmi, W. Harringer, J. Niedermeyer, M. Anssar, A. Kunsebeck, J. D. Schmitto, and A. Haverich Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 190 - 194. [Abstract] [Full Text] [PDF]

				M. Struber, J. M. Hohlfeld, S. Fraund, P. Kim, G. Warnecke, and A. Haverich Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 566 - 572. [Abstract] [Full Text] [PDF]

				D. Vlasselaers, G. M. Verleden, B. Meyns, D. Van Raemdonck, M. Demedts, A. Lerut, and P. Lauwers Femoral Venoarterial Extracorporeal Membrane Oxygenation for Severe Reimplantation Response After Lung Transplantation Chest, August 1, 2000; 118(2): 559 - 561. [Abstract] [Full Text] [PDF]

				B. F. Meyers, T. M. Sundt III, S. Henry, E. P. Trulock, T. Guthrie, J. D. Cooper, and G. A. Patterson Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 20 - 28. [Abstract] [Full Text] [PDF]

				S. M. Arcasoy and R. M. Kotloff Lung Transplantation N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091. [Full Text] [PDF]

				L. T. Eriksson, R. Roscher, R. Ingemansson, and S. Steen Cardiovascular effects of induced hypothermia after lung transplantation Ann. Thorac. Surg., March 1, 1999; 67(3): 804 - 809. [Abstract] [Full Text] [PDF]

				P. S. Myles Aspects of Anesthesia for Lung Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 140 - 154. [Abstract] [PDF]

				L. T. Eriksson and S. Steen Induced Hypothermia in Critical Respiratory Failure After Lung Transplantation Ann. Thorac. Surg., March 1, 1998; 65(3): 827 - 829. [Abstract] [Full Text] [PDF]